杭州比邻星创新投资管理
Investment Type: Venture Capital
Portfolio 2
| Date | Name | Website | Total Raised | Location |
| 08.09.2025 | Rapafusyn | rapafusyn.com | $72M | United Sta... |
| 10.08.2023 | DotBio | dotbio.com | $5.6M | United Sta... |
Mentions in press and media 2
| Date | Title | Description |
| 16.10.2025 | BridGene Biosciences Raises $28M in Series B+ Funding | BridGene Biosciences, Inc., a San Jose, CA-based leader in the discovery and development of small molecule drugs for traditionally “hard-to-drug” targets, closed a $28m Series B+ financing round. The round was led by Bayland Capital, with p... |
| 08.09.2025 | Rapafusyn Pharmaceuticals Closes $44M Series A Financing | Rapafusyn Pharmaceuticals, a Baltimore, MD-based company which specializes in the discovery and development of non-degrading molecular glue therapeutics, raised $44M in Series A funding. The round was led by BioTrack Capital and Yonjin Capi... |